Bridge to HOPE Trial
Clinical validation for HOPE in liver transplantation
N/A (Post-market study)Active
Key Facts
Indication
Clinical validation for HOPE in liver transplantation
Phase
N/A (Post-market study)
Status
Active
Company
About Bridge To Life
Bridge to Life is a commercial-stage, private company and a recognized leader in the organ preservation and perfusion market. Its core offerings include the established Belzer UW® static cold storage solutions and the innovative VitaSmart™ HOPE system, which has recently gained FDA clearance and seen its first commercial use in the U.S. The company is strategically positioned to address the critical shortage of viable donor organs by extending preservation times and improving organ quality, thereby aiming to increase transplant success rates and save more lives.
View full company profile